TABLE 2.
Hemostatic parameters of women with PPH
| Severe PPH (n = 82) | Non‐severe PPH (n = 308) | Total (n = 390) | ||||
|---|---|---|---|---|---|---|
| Median (IQR) | >15% | Median (IQR) | >15% | Median (IQR) | >15% | |
| APTEM ML | 3% (1–5) | 3% (1–4) | 3% (1–4) | |||
| EXTEM ML | 3% (1–5) | 3 (3.7) a | 3% (1–5) | 3 (1.0) a | 3% (1–5) | 6 (1.5) a |
| EFI c | 0% (−1 to 0) | 2 (2.4) b | 0% (−0.5 to 1) | 2 (0.6) b | 0% (−1 to 1) | 4 (1.0) b |
Abbreviations: EFI =EXTEM (ML) – APTEM (ML). EFI, enzymatic fibrinolysis index; APTEM (ML), ROTEM® test activated by tissue factor in the presence of the anti‐fibrinolytic agent aprotinin; EXTEM (ML), ROTEM® test activated by tissue factor in the absence of the anti‐fibrinolytic agent aprotinin.
a
Number of participants with EXTEM ML >15%, reported as number of women with (%).
b
Number of participants with EFI >15%, reported as number of women with (%).
c
Hyperfibrinolysis is defined as EFI >15%.